Dr. Paul Michael Charpentier, MD

Dr. Charpentier practices at Gualala Health Center in Gualala, California.

Dr. Charpentier's NPI, 1740542380, was assigned on June 11, 2012. Dr. Charpentier graduated from Northeastern Ohio University College of Medicine in 2012. Dr. Charpentier holds California license A155923.

Dr. Charpentier's primary practice is Gualala Health Center, at 46900 Ocean Drive, Gualala, CA 95445 in Mendocino County. The practice phone is (707) 884-4005.

Dr. Charpentier's primary practice is Gualala Health Center in Gualala, California. Dr. Charpentier is also affiliated with Adventist Health Ukiah Valley. The medical group on file is Redwood Coast Medical Services. Dmand AI also links Dr. Charpentier to 4 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account. Dr. Charpentier's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Charpentier practices, 9 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Charpentier's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Charpentier's licenses on file in 2 states: California and Michigan.

CMS data shows 596 Medicare services from Dr. Charpentier across 11 procedure codes in 2024, for 390 Medicare patients. Medicare paid $271,160 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 390 Medicare patients who saw Dr. Charpentier in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have arthritis, and 73% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Charpentier's median patient age at 73, with 61% women.

In 2024, Dr. Charpentier wrote 504 Medicare Part D claims for 228 patients. 99% of them were for generic drugs. CMS names the drug for 452 of them, across 11 drugs with 11 or more claims each, at $3,743 in total drug cost. In 2023, CMS named 403 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Charpentier for performance year 2024, reported through an alternative payment model (APM). Dr. Charpentier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 99 procedures of hip replacement by Dr. Charpentier, more than 97% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Charpentier. The most frequent topics are Bone Plates, Bone Screws and Arthroplasty, Replacement, Knee. Dr. Charpentier's most frequent co-authors are Ajay Kumar Srivastava, MD, Osy Bosah Ndubaku, MD and James Douglas Ostrander, MD.

CMS Open Payments shows 61 general payments to Dr. Charpentier from 10 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 57% of the total. Stryker Corporation paid the most, $2,802.

Dr. Charpentier graduated from Northeastern Ohio University College of Medicine in 2012.